<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04516330</url>
  </required_header>
  <id_info>
    <org_study_id>MCBC-MIR</org_study_id>
    <nct_id>NCT04516330</nct_id>
  </id_info>
  <brief_title>Can MicroRNA's Predict Multicentricity in Breast Cancer?</brief_title>
  <official_title>Can MicroRNA's Predict Multicentricity in Breast Cancer?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bezmialem Vakif University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine if microRNA's have role in predicting multicentricity&#xD;
      in breast cancer. If a specific microRNA will be found to be related with multicentricity, it&#xD;
      will help us to make appropriate decisions on the treatment of patients with multicentric&#xD;
      breast cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the study that will be held at Bezmialem Vakif University Medical Faculty, General Surgery&#xD;
      Department, 20 unifocal and 20 multifocal breast cancer patients will be included. Tissues&#xD;
      will be taken from both tumoral and normal breast tissues and they will be saved in microRNA&#xD;
      later solution under -80Â°C. Then, 84 microRNA's will be studied in these tissues to see if&#xD;
      they express any of these microRNA's.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">April 2019</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MicroRNA's in multicentric breast cancer</measure>
    <time_frame>April 2014</time_frame>
    <description>Evaluation of 84 microRNA's in patients with multicentric breast cancer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment plan according to the detected microRNA in patients with multicentric breast cancer</measure>
    <time_frame>April 2014</time_frame>
    <description>If a specific microRNA will be detected in patients with multicentric breast cancer, treatment plan will be individualized according to the detected microRNA</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Multicentric Breast Cancer</condition>
  <arm_group>
    <arm_group_label>unifocal breast cancer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients having unifocal breast cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>multicentric breast cancer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients having multicentric breast cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>miRNA</intervention_name>
    <description>miRNA's expressed in breast cancer</description>
    <arm_group_label>multicentric breast cancer</arm_group_label>
    <arm_group_label>unifocal breast cancer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Having breast cancer&#xD;
&#xD;
          2. Having no other malignancy&#xD;
&#xD;
          3. Female patient&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Having other malignancy&#xD;
&#xD;
          2. Under 18 years old&#xD;
&#xD;
          3. Male patient&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bezmialem Vakif University</name>
      <address>
        <city>Istanbul</city>
        <zip>34306</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>December 10, 2013</study_first_submitted>
  <study_first_submitted_qc>August 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2020</study_first_posted>
  <last_update_submitted>August 14, 2020</last_update_submitted>
  <last_update_submitted_qc>August 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bezmialem Vakif University</investigator_affiliation>
    <investigator_full_name>Yeliz Emine Ersoy</investigator_full_name>
    <investigator_title>Assoc. Prof.</investigator_title>
  </responsible_party>
  <keyword>multicentric</keyword>
  <keyword>breast</keyword>
  <keyword>cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

